PTPRC and neoplasm: There was no difference in the percentages of tumor-infiltrating CD8+CD44+ T cells observed between the different treatment groups, and no tumor-infiltrating CD4+CD44+ T cells gated from CD45+CD3+ cells were detected in our study (data not shown).